Urology endoscopes are devices that are used in medical procedure to examine the urinary tract including the bladder, ureters, and kidneys. The procedure that involves the insertion of a scope into the bladder and further inside the ureter is known as the ‘retrograde’ approach to endoscopy. This approach is used to pass a plastic tube, called a stent, into the ureter to connect the kidney to the bladder. The stent enables the bypass of stones, structures, or blockage of the ureter in order to drain urine. The second approach called ‘antegrade’ or ‘percutaneous’ endoscopy involves reaching the kidney through the skin. It involves the use of a nephroscope for inspection of urinary stones and thus their removal with the help of flexible forceps/tipless stone baskets, or by flushing the stone into the system for removal through the natural route.
Endoscopes are utilized for various sub-disciplines of urology, including cystoscopy, andrology, endourology, laparoscopy, pediatric urology, and urologic oncology. Endourology includes all minimally invasive urologic surgical procedures and uses small cameras and instruments, which are inserted into the urinary tract. Laparoscopy includes surgeries of the prostate, kidney, and ureter, among others and uses endoscopes, while cystoscopy involves endoscopy of the urinary bladder via the urethra with the help of an instrument called the cystoscope.
In 2013, North America accounted for the largest share in the global urology endoscope devices market. The market was valued at $123.5 million in 2013 and is expected to grow at a CAGR of 6.3% from 2013 to 2018. The market is likely to be propelled by technological advancements in the field of urologic surgery. The growth of this market will be driven in part by the movement towards digital endoscopes which are more expensive. Increases in urological procedures, such as biopsies, urinary stone treatments, and the need for diagnostic or exploratory procedures, are expected to raise the number of endoscopes sold through 2020.
Some of the urology endoscopes available in the market are Ureterorenoscopes (Olympus Medical Systems Corporation), Resectoscopes (Stryker Corporation), Pediatric Cysto-urethro-fiberscopes (Karl Storz GmbH & Co. KG), FAZONE CB (Fujifilm Holdings Corporation), and Flexor Vue Deflecting Endoscopic System (Cook Group).
The report on the North American urology endoscopes market provides an extensive competitive landscape of companies operating in this market. The key players of the market covered in the report are C. R. Bard, Inc., Olympus Corporation, Karl Storz, Covidien plc, Boston Scientific, Stryker Corporation, Fujifilm Holdings Corporation, and Cook Group.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints, and upcoming opportunities in the market. Details of the segment and country-specific shares, news and deals, M & A, segment-specific pipeline products, product approvals, and product recalls of major companies have also been covered in the report.
Customization Options
Along with market data, you can also customize MMM assessments that meet your company’s specific needs. Customize your report on the North American urology endoscopes market to get comprehensive industry standards and a deep-dive analysis of the following parameters.
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix, which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Procedure Volume Data
- Different types of urological endoscopy procedures performed annually in North America tracked till sub-segment level
- Number of urinary bladder, ureter, and kidney procedures performed by endoscopy in North America
Pricing Trends
- Cost analysis of urological endoscope devices in North America
Competitive Intelligence
- Company share analysis of top market players in the region
- Crucial developments and strategies of companies inculcating urology endoscopes in their portfolios
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE | PUBLISHED | |
---|---|---|
North American Rigid Endoscopes Market The North American Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $1.03billion in 2013 and expected to be $1.41 billion by 2018, growing at a CAGR of 6.5%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming | |
European Rigid Endoscopes Market The European Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.66 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 5.4%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming | |
Asian Rigid Endoscopes Market The Asian Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.61 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 7.2%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |